Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mendel

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
International Journal of Peptide and Protein Research|April 1, 1996
Isolation and characterization of a trisulfide variant of recombinant human growth hormone formed during expression in Escherichia coliC Andersson, P O Edlund, P Gellerfors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignanciesCheryl A London, Alison L Hannah, Regina Zadovoskaya, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Cancer Research|November 13, 2003
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivoJames G Christensen, Randall Schreck, Jon Burrows, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in miceXiaohua Xin, Tinya J Abrams, Paul W Hollenbach, et al.
Molecular Cancer Therapeutics|August 8, 2006
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activityShem Patyna, A Douglas Laird, Dirk B Mendel, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipDirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
International Journal of Peptide and Protein Research|April 1, 1996
Isolation and characterization of a trisulfide variant of recombinant human growth hormone formed during expression in Escherichia coliC Andersson, P O Edlund, P Gellerfors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignanciesCheryl A London, Alison L Hannah, Regina Zadovoskaya, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Cancer Research|November 13, 2003
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivoJames G Christensen, Randall Schreck, Jon Burrows, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in miceXiaohua Xin, Tinya J Abrams, Paul W Hollenbach, et al.
Molecular Cancer Therapeutics|August 8, 2006
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activityShem Patyna, A Douglas Laird, Dirk B Mendel, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipDirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Pageof 11